INSIDER · CIK 1763494
Dube Eric M
CHIEF EXECUTIVE OFFICER, Director at Travere Therapeutics, Inc. (TVTX)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$38.5MSold on the market
1Companies
Oct 19, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202616:05 | Oct 15, 2026 | TVTXTravere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | S · Sell10b5-1 | $53.82 | −243,735 | 432,886 | -36% | −$13.1M | ||
| Oct 19, 202616:05 | Oct 15, 2026 | TVTXTravere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | M · Exercise10b5-1 | $12.15 | +243,735 | 676,621 | +56% | $3.0M | ||
| Sep 17, 202621:31 | Sep 17, 2026from Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | S · Sell10b5-1 | $63.48 | −400,000 | 432,886 | -48% | −$25.4M | ||
| Sep 17, 202621:31 | Sep 17, 2026from Sep 15, 2026 | TVTXTravere Therapeutics, Inc. | CHIEF EXECUTIVE OFFICER, Director | M · Exercise10b5-1 | $23.34 | +400,000 | 541,379 | +283% | $9.3M |